 | • レポートコード：MRC23Q35748 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（2-3日） • 産業分類：医療 |
| Single User | ￥429,200 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥858,400 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の全長ORFクローン市場について調査・分析し、世界の全長ORFクローン市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（哺乳類発現系、レンチウイルス発現系、細菌発現系、酵母発現系、昆虫、小麦胚芽細胞、その他）、用途別セグメント分析（バイオテクノロジー企業、製薬企業、受託研究機関、学術・研究機関）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Thermo Fisher Scientific、GeneCopoeia、Dharmacon、BioCat GmbH、Source BioScience、Kabushiki Kaisha (KK)、GenScript、OriGene Technologies、Sino Biological、Promegaなどが含まれています。世界の全長ORFクローン市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、全長ORFクローン市場規模を推定する際に考慮しました。本レポートは、全長ORFクローンの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、全長ORFクローンに関するビジネス上の意思決定に役立てることを目的としています。 ・全長ORFクローン市場の概要 - 全長ORFクローンのタイプ別セグメント - 世界の全長ORFクローン市場規模：タイプ別分析（哺乳類発現系、レンチウイルス発現系、細菌発現系、酵母発現系、昆虫、小麦胚芽細胞、その他） - 全長ORFクローンの用途別セグメント - 世界の全長ORFクローン市場規模：用途別分析（バイオテクノロジー企業、製薬企業、受託研究機関、学術・研究機関） - 世界の全長ORFクローン市場規模予測（2018年-2029年） ・全長ORFクローン市場の成長トレンド - 全長ORFクローンの地域別市場規模（2018年-2029年） - 全長ORFクローン市場ダイナミクス - 全長ORFクローンの業界動向 - 全長ORFクローン市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：哺乳類発現系、レンチウイルス発現系、細菌発現系、酵母発現系、昆虫、小麦胚芽細胞、その他 - 世界の全長ORFクローンのタイプ別市場規模（2018年-2023年） - 世界の全長ORFクローンのタイプ別市場規模（2024年-2029年） ・用途別セグメント：バイオテクノロジー企業、製薬企業、受託研究機関、学術・研究機関 - 世界の全長ORFクローンの用途別市場規模（2018年-2023年） - 世界の全長ORFクローンの用途別市場規模（2024年-2029年） ・全長ORFクローンの地域別市場規模 - 北米の全長ORFクローン市場規模（2018年-2029年） - アメリカの全長ORFクローン市場規模（2018年-2029年） - ヨーロッパの全長ORFクローン市場規模（2018年-2029年） - アジア太平洋の全長ORFクローン市場規模（2018年-2029年） - 中国の全長ORFクローン市場規模（2018年-2029年） - 日本の全長ORFクローン市場規模（2018年-2029年） - 韓国の全長ORFクローン市場規模（2018年-2029年） - インドの全長ORFクローン市場規模（2018年-2029年） - オーストラリアの全長ORFクローン市場規模（2018年-2029年） - 中南米の全長ORFクローン市場規模（2018年-2029年） - 中東・アフリカの全長ORFクローン市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Thermo Fisher Scientific、GeneCopoeia、Dharmacon、BioCat GmbH、Source BioScience、Kabushiki Kaisha (KK)、GenScript、OriGene Technologies、Sino Biological、Promega ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global A full-length ORF (Open Reading Frame) Clone market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for A full-length ORF (Open Reading Frame) Clone is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for A full-length ORF (Open Reading Frame) Clone is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for A full-length ORF (Open Reading Frame) Clone in Biotechnology Companies is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of A full-length ORF (Open Reading Frame) Clone include Thermo Fisher Scientific, GeneCopoeia, Dharmacon, BioCat GmbH, Source BioScience, Kabushiki Kaisha (KK), GenScript, OriGene Technologies and Sino Biological, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for A full-length ORF (Open Reading Frame) Clone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding A full-length ORF (Open Reading Frame) Clone.
The A full-length ORF (Open Reading Frame) Clone market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global A full-length ORF (Open Reading Frame) Clone market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the A full-length ORF (Open Reading Frame) Clone companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Thermo Fisher Scientific
GeneCopoeia
Dharmacon
BioCat GmbH
Source BioScience
Kabushiki Kaisha (KK)
GenScript
OriGene Technologies
Sino Biological
Promega
Segment by Type
Mammalian Expression System
Lentiviral Expression System
Bacterial Expression System
Yeast Expression System
Insect
Wheat Germ Cell
Others
Segment by Application
Biotechnology Companies
Pharmaceutical Companies
Contract Research Organizations
Academic/ Research Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of A full-length ORF (Open Reading Frame) Clone companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global A full-length ORF (Open Reading Frame) Clone Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Mammalian Expression System
1.2.3 Lentiviral Expression System
1.2.4 Bacterial Expression System
1.2.5 Yeast Expression System
1.2.6 Insect
1.2.7 Wheat Germ Cell
1.2.8 Others
1.3 Market by Application
1.3.1 Global A full-length ORF (Open Reading Frame) Clone Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Biotechnology Companies
1.3.3 Pharmaceutical Companies
1.3.4 Contract Research Organizations
1.3.5 Academic/ Research Institutes
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global A full-length ORF (Open Reading Frame) Clone Market Perspective (2018-2029)
2.2 A full-length ORF (Open Reading Frame) Clone Growth Trends by Region
2.2.1 Global A full-length ORF (Open Reading Frame) Clone Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 A full-length ORF (Open Reading Frame) Clone Historic Market Size by Region (2018-2023)
2.2.3 A full-length ORF (Open Reading Frame) Clone Forecasted Market Size by Region (2024-2029)
2.3 A full-length ORF (Open Reading Frame) Clone Market Dynamics
2.3.1 A full-length ORF (Open Reading Frame) Clone Industry Trends
2.3.2 A full-length ORF (Open Reading Frame) Clone Market Drivers
2.3.3 A full-length ORF (Open Reading Frame) Clone Market Challenges
2.3.4 A full-length ORF (Open Reading Frame) Clone Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top A full-length ORF (Open Reading Frame) Clone Players by Revenue
3.1.1 Global Top A full-length ORF (Open Reading Frame) Clone Players by Revenue (2018-2023)
3.1.2 Global A full-length ORF (Open Reading Frame) Clone Revenue Market Share by Players (2018-2023)
3.2 Global A full-length ORF (Open Reading Frame) Clone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by A full-length ORF (Open Reading Frame) Clone Revenue
3.4 Global A full-length ORF (Open Reading Frame) Clone Market Concentration Ratio
3.4.1 Global A full-length ORF (Open Reading Frame) Clone Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by A full-length ORF (Open Reading Frame) Clone Revenue in 2022
3.5 A full-length ORF (Open Reading Frame) Clone Key Players Head office and Area Served
3.6 Key Players A full-length ORF (Open Reading Frame) Clone Product Solution and Service
3.7 Date of Enter into A full-length ORF (Open Reading Frame) Clone Market
3.8 Mergers & Acquisitions, Expansion Plans
4 A full-length ORF (Open Reading Frame) Clone Breakdown Data by Type
4.1 Global A full-length ORF (Open Reading Frame) Clone Historic Market Size by Type (2018-2023)
4.2 Global A full-length ORF (Open Reading Frame) Clone Forecasted Market Size by Type (2024-2029)
5 A full-length ORF (Open Reading Frame) Clone Breakdown Data by Application
5.1 Global A full-length ORF (Open Reading Frame) Clone Historic Market Size by Application (2018-2023)
5.2 Global A full-length ORF (Open Reading Frame) Clone Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America A full-length ORF (Open Reading Frame) Clone Market Size (2018-2029)
6.2 North America A full-length ORF (Open Reading Frame) Clone Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America A full-length ORF (Open Reading Frame) Clone Market Size by Country (2018-2023)
6.4 North America A full-length ORF (Open Reading Frame) Clone Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe A full-length ORF (Open Reading Frame) Clone Market Size (2018-2029)
7.2 Europe A full-length ORF (Open Reading Frame) Clone Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe A full-length ORF (Open Reading Frame) Clone Market Size by Country (2018-2023)
7.4 Europe A full-length ORF (Open Reading Frame) Clone Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific A full-length ORF (Open Reading Frame) Clone Market Size (2018-2029)
8.2 Asia-Pacific A full-length ORF (Open Reading Frame) Clone Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific A full-length ORF (Open Reading Frame) Clone Market Size by Region (2018-2023)
8.4 Asia-Pacific A full-length ORF (Open Reading Frame) Clone Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America A full-length ORF (Open Reading Frame) Clone Market Size (2018-2029)
9.2 Latin America A full-length ORF (Open Reading Frame) Clone Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America A full-length ORF (Open Reading Frame) Clone Market Size by Country (2018-2023)
9.4 Latin America A full-length ORF (Open Reading Frame) Clone Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa A full-length ORF (Open Reading Frame) Clone Market Size (2018-2029)
10.2 Middle East & Africa A full-length ORF (Open Reading Frame) Clone Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa A full-length ORF (Open Reading Frame) Clone Market Size by Country (2018-2023)
10.4 Middle East & Africa A full-length ORF (Open Reading Frame) Clone Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific A full-length ORF (Open Reading Frame) Clone Introduction
11.1.4 Thermo Fisher Scientific Revenue in A full-length ORF (Open Reading Frame) Clone Business (2018-2023)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 GeneCopoeia
11.2.1 GeneCopoeia Company Detail
11.2.2 GeneCopoeia Business Overview
11.2.3 GeneCopoeia A full-length ORF (Open Reading Frame) Clone Introduction
11.2.4 GeneCopoeia Revenue in A full-length ORF (Open Reading Frame) Clone Business (2018-2023)
11.2.5 GeneCopoeia Recent Development
11.3 Dharmacon
11.3.1 Dharmacon Company Detail
11.3.2 Dharmacon Business Overview
11.3.3 Dharmacon A full-length ORF (Open Reading Frame) Clone Introduction
11.3.4 Dharmacon Revenue in A full-length ORF (Open Reading Frame) Clone Business (2018-2023)
11.3.5 Dharmacon Recent Development
11.4 BioCat GmbH
11.4.1 BioCat GmbH Company Detail
11.4.2 BioCat GmbH Business Overview
11.4.3 BioCat GmbH A full-length ORF (Open Reading Frame) Clone Introduction
11.4.4 BioCat GmbH Revenue in A full-length ORF (Open Reading Frame) Clone Business (2018-2023)
11.4.5 BioCat GmbH Recent Development
11.5 Source BioScience
11.5.1 Source BioScience Company Detail
11.5.2 Source BioScience Business Overview
11.5.3 Source BioScience A full-length ORF (Open Reading Frame) Clone Introduction
11.5.4 Source BioScience Revenue in A full-length ORF (Open Reading Frame) Clone Business (2018-2023)
11.5.5 Source BioScience Recent Development
11.6 Kabushiki Kaisha (KK)
11.6.1 Kabushiki Kaisha (KK) Company Detail
11.6.2 Kabushiki Kaisha (KK) Business Overview
11.6.3 Kabushiki Kaisha (KK) A full-length ORF (Open Reading Frame) Clone Introduction
11.6.4 Kabushiki Kaisha (KK) Revenue in A full-length ORF (Open Reading Frame) Clone Business (2018-2023)
11.6.5 Kabushiki Kaisha (KK) Recent Development
11.7 GenScript
11.7.1 GenScript Company Detail
11.7.2 GenScript Business Overview
11.7.3 GenScript A full-length ORF (Open Reading Frame) Clone Introduction
11.7.4 GenScript Revenue in A full-length ORF (Open Reading Frame) Clone Business (2018-2023)
11.7.5 GenScript Recent Development
11.8 OriGene Technologies
11.8.1 OriGene Technologies Company Detail
11.8.2 OriGene Technologies Business Overview
11.8.3 OriGene Technologies A full-length ORF (Open Reading Frame) Clone Introduction
11.8.4 OriGene Technologies Revenue in A full-length ORF (Open Reading Frame) Clone Business (2018-2023)
11.8.5 OriGene Technologies Recent Development
11.9 Sino Biological
11.9.1 Sino Biological Company Detail
11.9.2 Sino Biological Business Overview
11.9.3 Sino Biological A full-length ORF (Open Reading Frame) Clone Introduction
11.9.4 Sino Biological Revenue in A full-length ORF (Open Reading Frame) Clone Business (2018-2023)
11.9.5 Sino Biological Recent Development
11.10 Promega
11.10.1 Promega Company Detail
11.10.2 Promega Business Overview
11.10.3 Promega A full-length ORF (Open Reading Frame) Clone Introduction
11.10.4 Promega Revenue in A full-length ORF (Open Reading Frame) Clone Business (2018-2023)
11.10.5 Promega Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details